Gilead Sciences, Inc. is listed in the United States. Sector: Healthcare. Industry: Drug Manufacturers - General.
Gilead Sciences, Inc. (GILD): research close 170.26 USD on 2026-11-17. 52-week range 117.63 to 174.48 USD. Historical research data, not advice.
| Fact | Figure | As of |
|---|---|---|
| Historical research close | 170.26 USD | 2026-11-17 |
| Previous research close | 167.58 USD | 2026-11-16 |
| Change between the two dated research closes | 1.60% | 2026-11-16 – 2026-11-17 |
| Market capitalisation | 207.79 billion USD | 2026-11-16 |
| 52-week range of the research close | 117.63 – 174.48 USD | 2025-11-18 – 2026-11-17 |
| One-year change in the research close | 38.91% | 2025-11-17 – 2026-11-17 |
| Average daily turnover (20 sessions) | 1.08 billion USD | 2026-11-17 |
Source: us_closes_adjusted · US · research close
Historical research prices; adjustments vary by market. This is not a live quote or a forecast.
Members can compare available company evidence and explicitly save GILD to a watchlist. A company is saved only after Save is pressed for it.
Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.
Nine member offerings. Free. No card.
Join freeResearch, not advice.
Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate